We want to inform our patients and the community about an important update regarding Saxenda® (liraglutide injection).
The manufacturer has announced that the production and commercial availability of Saxenda® will be discontinued as of March 2026. It is important to note that this decision is not due to any safety or quality concerns with the medication.
(more…)